An Executive Perspective: How AI Is Shaping The Future Of Integrated Care is starting in

Bill Gates Invests In Alzheimer’s Diagnosis Test

Billionaire entrepreneur and philanthropist Bill Gates recently invested $30 million in efforts to develop a diagnostic test for Alzheimer’s disease. The investment comes as part of a collaborative effort with numerous other philanthropists via the Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostic Accelerator.

The Diagnostic Accelerator is an effort by ADDF to utilize philanthropic and venture capital principals to help create more accurate Alzheimer’s diagnostic tests. Currently available tests for Alzheimer’s are expensive and invasive for consumers. The Diagnostics Accelerator will help empower the research community to develop cutting-edge biomarkers and explore novel diagnostic technologies . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!